Schweinfurthin induces ICD without ER stress and caspase activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Schweinfurthin induces ICD without ER stress and caspase activation

Published:2022-08-03 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Ruoheng,Neighbors J.D.¹²³,Schell T.D.³⁴,Hohl R.J.¹²³

Affiliation:

1. Department of Medicine, Penn State College of Medicine, Hershey, PA, USA

2. Department of Pharmacology, Penn State College of Medicine, Hershey, PA, USA

3. Penn State Cancer Institute, Hershey, PA, USA

4. Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, USA

Funder

Penn State Cancer Institute

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2104551

Reference78 articles.

1. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

2. Cancer immunotherapy using checkpoint blockade

3. Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?

4. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

5. Immunogenic Cell Death Induction by Ionizing Radiation

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products;Phytomedicine;2024-09

2. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment;Biomedicine & Pharmacotherapy;2024-08

3. CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity;Frontiers in Immunology;2024-07-01

4. Immunogenic cell stress and death in the treatment of cancer;Seminars in Cell & Developmental Biology;2024-03

5. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds;Cancer Cell International;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3